Symbiotic bacteria can be found living in and on the majority of our body’s surfaces, with 99 percent of these micro-interlopers inhabiting the human gastrointestinal tract. These intestinal microbes are … Continue Reading Augmented bacteriophage modulates gut microbiota to fight cancer.
Being able to detect early on whether a cancer therapy is working proffers obvious benefits for therapy-outcomes whilst influencing the course of treatment and improving the quality of life for … Continue Reading Novel ‘reporter’ nanoparticle reveals cancer treatment effectiveness in real-time.
The primary role of monocytes is to sense the environment and replenish the pool of tissue macrophages and dendritic cells. Recent advances in immunology research have discovered that monocytes can … Continue Reading Role finally identified for subset of white blood cells in cancer metastasis.
Tumours are known to evade the immune system by a variety of mechanisms, one of which is the recruitment of ‘myeloid-derived suppressor cells’ (MDSC). MDSCs suppress the ability of the … Continue Reading Researchers uncover more about the elusive pericyte-tumour interaction.
A main barrier to immune therapy success has been the tumour’s ability to keep the immune system from functioning against the cancer. The immune cells are there, however, like an … Continue Reading Researchers use ‘demethylating’ precision medicine to fight cancer.
To be activated, T cells must first recognize an antigen, receive appropriate costimulatory signals, and then encounter inflammatory cytokines to expand the immune response. This immune response has been harnessed … Continue Reading New T-cell regulation discovery set to rewrite immunology text books.
In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumour tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, … Continue Reading Activated immune cells indicate a favourable prognosis in colorectal cancer.
Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop precision medical vaccines to treat … Continue Reading Researchers develop first individualised precise medical vaccine for ovarian cancer.
A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is … Continue Reading Novel vaccine decreases recurrence in HER2 breast cancer patients.
Researchers at Children’s Hospital Los Angeles have shown that a select team of immune-system cells from patients with leukemia can be multiplied in the lab, creating an army of natural … Continue Reading Natural (born) killer cells battle pediatric leukemia.